(C) Cell cycle profiles of synchronized HeLa cells in Fig 3B determined by flow cytometry (D) HeLa cells expressing full-length GFP-SDE2 was treated with 1 M MLN4924 and irradiated with 40 J/m2 UVC for 4 h. is usually processed to release its UBL. To determine the size of full-length and cleaved SDE2, cell lysates expressing C-terminal Flag-tagged SDE2 wild-type or GA mutants were analyzed by Western blotting with anti-Flag and anti-SDE2 antibodies. The epitope of SDE2 antibody falls within amino acids 318C410. Only fully processed endogenous SDE2 is usually detected (compare lanes 1 and 3). * denotes nonspecific bands.(TIF) pgen.1006465.s002.tif (5.0M) GUID:?C08C3F98-F00D-4EC3-B5C3-5EC42AD5262A S2 Fig: Conversation of SDE2 with PCNA (Related to Fig 2). (A) Analysis of the SDE2 PIP box. Both canonical and non-canonical PIP boxes from several known PIP-box-containing proteins are offered, and conserved elements are marked in reddish. (B) Conversation of GFP-SDE2-UBL with PCNA. 293T cell lysates expressing GFP-SDE2-UBL wild-type or PIP mutant (F47A & F48A) were incubated with GST- or GST-PCNA-bound glutathione beads and analyzed by Western blotting. (C) SDE2-Flag proteins transcribed and translated (IVTT) from reticulocyte lysates were analyzed by Western Pelitinib (EKB-569) blotting. Where indicated, 5 M ubiquitin aldehyde (Ub-Al) was added during expression. (D) Expression of full-length GST-tagged SDE2. GST-SDE2 was induced from your BL21 strain by 0.5 mM IPTG at 30C. Proteins were captured with glutathione-conjugated beads and visualized by Coomassie staining. (E) Conserved cysteine or histidine-glutamate residues are not required for SDE2 cleavage. The indicated SDE2-Flag wild-type or point mutants were transcribed and translated, and cleaved SDE2-Flag proteins were analyzed by Western blotting.(TIF) pgen.1006465.s003.tif (2.0M) GUID:?F0492324-FC55-481E-BA76-87BCBFA2B4C2 S3 Fig: Degradation of SDE2-UBL (Related to Fig 3). (A) Sequence alignment of PIP degron motifs present in known CDT2 substrates. Canonical PIP residues are shown in reddish, and PIP degron-specific residues Pelitinib (EKB-569) are shown in blue. Several substrates lack elements constituting a classical PIP degron. (B) DNA-damage dependent degradation of SDE2-UBL is usually mediated by the proteasome. HeLa cells expressing GFP-SDE2 were left untreated (Unt) or treated with 40 J/m2 ultraviolet C (UVC) for 4 h, 2 mM hydroxyurea (HU) for 8 h, and 1 M mitomycin C (MMC) for 16 h, and cellular GFP-UBL levels were analyzed by Western blotting. Where indicated, cells were treated with 10 M MG132 for 4 h before harvest. (C) Cell cycle profiles of synchronized HeLa cells in Fig 3B determined by circulation cytometry (D) HeLa cells expressing full-length GFP-SDE2 was treated with 1 M MLN4924 and irradiated with 40 J/m2 UVC for 4 h. The GFP-UBL levels were analyzed by Western blotting. (E) GFP-SDE2-expressing HeLa cells transfected with siRNA control or CDT2 were synchronized by 100 ng/mL nocodazole at the G2/M phase and released for 2 h. The GFP-UBL levels were analyzed by Western blotting.(TIF) pgen.1006465.s004.tif (1.7M) GUID:?BF0E468F-76D7-47EA-9577-A550F45D9EA0 S4 Fig: The elements required for degradation of Pelitinib (EKB-569) C-SDE2 (Related to Fig 4). (A) Degradation of C-SDE2 is usually proteasome-dependent. HeLa cells were left untreated or treated with 40 J/m2 UVC for 4 h, fractionated into cytosolic/nucleoplasmic (S) and chromatin-enriched (P) fractions using CSK buffer, and the endogenous C-SDE2 levels were analyzed by Western blotting. Where indicated, cells were treated with 10 M MG132 for 4 h before harvest. (B) C-SDE2 levels are regulated in a cell cycle-dependent manner. HeLa cells were synchronized with nocodazole for 12 h and released into new medium after mitotic shake-off. Cells were harvested at the indicated occasions, and endogenous C-SDE2 levels were analyzed by Western blotting. The cell-cycle dependent switch of C-SDE2 association in chromatin is usually quantified by ImageJ and indicated below the blots. (C, D) The half-life of C-SDE2 is usually extended by SAP or GA mutations. (top) HeLa cells expressing full-length SDE2-Flag wild-type or mutants were with 50 g/mL of CHX, and cell lysates were analyzed by Western blotting. (bottom) Quantification of immunoblots by Image J. The dotted collection indicates a half-life. (E) CDT2 is required for the Rabbit Polyclonal to PTPN22 degradation of C-SDE2 during cell cycle Pelitinib (EKB-569) progression. HeLa cells transfected with siRNA control or CDT2 were synchronized with.
Recent Comments
Archives
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
Categories
- Orexin Receptors
- Orexin, Non-Selective
- Orexin1 Receptors
- Organic Anion Transporting Polypeptide
- ORL1 Receptors
- Ornithine Decarboxylase
- Orphan 7-TM Receptors
- Orphan 7-Transmembrane Receptors
- Orphan G-Protein-Coupled Receptors
- Orphan GPCRs
- OT Receptors
- Other Acetylcholine
- Other Adenosine
- Other Apoptosis
- Other ATPases
- Other Calcium Channels
- Other Cannabinoids
- Other Channel Modulators
- Other Dehydrogenases
- Other Hydrolases
- Other Ion Pumps/Transporters
- Other Kinases
- Other MAPK
- Other Nitric Oxide
- Other Nuclear Receptors
- Other Oxygenases/Oxidases
- Other Peptide Receptors
- Other Pharmacology
- Other Product Types
- Other Proteases
- Other RTKs
- Other Synthases/Synthetases
- Other Tachykinin
- Other Transcription Factors
- Other Transferases
- Other Wnt Signaling
- OX1 Receptors
- OXE Receptors
- Oxidative Phosphorylation
- Oxoeicosanoid receptors
- Oxygenases/Oxidases
- Oxytocin Receptors
- P-Glycoprotein
- P-Selectin
- P-Type ATPase
- P-Type Calcium Channels
- p14ARF
- p160ROCK
- P2X Receptors
- P2Y Receptors
- p38 MAPK
- p53
- p56lck
- p60c-src
- p70 S6K
- p75
- p90 Ribosomal S6 Kinase
- PAC1 Receptors
- PACAP Receptors
- PAF Receptors
- PAO
- PAR Receptors
- Parathyroid Hormone Receptors
- PARP
- PC-PLC
- PDE
- PDGFR
- PDK1
- PDPK1
- Peptide Receptor, Other
- Peptide Receptors
- Peroxisome-Proliferating Receptors
- PGF
- PGI2
- Phosphatases
- Phosphodiesterases
- Phosphoinositide 3-Kinase
- Phosphoinositide-Specific Phospholipase C
- Phospholipase A
- Phospholipase C
- Phospholipases
- Phosphorylases
- Photolysis
- PI 3-Kinase
- PI 3-Kinase/Akt Signaling
- PI-PLC
- PI3K
- Pim Kinase
- Pim-1
- PIP2
- Pituitary Adenylate Cyclase Activating Peptide Receptors
- PKA
- PKB
- PKC
- PKD
- PKG
- PKM
- PKMTs
- PLA
- Plasmin
- Platelet Derived Growth Factor Receptors
- Platelet-Activating Factor (PAF) Receptors
- Uncategorized